Precigen, Inc. – ‘10-K’ for 12/31/23 – ‘ZIP’

On:  Tuesday, 3/19/24, at 4:48pm ET   ·   For:  12/31/23   ·   Accession #:  1356090-24-7   ·   File #:  1-36042

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.43M 
 3: EX-10.10    Material Contract                                   HTML     46K 
 4: EX-10.11    Material Contract                                   HTML     48K 
 2: EX-10.9     Material Contract                                   HTML     42K 
 5: EX-21.1     Subsidiaries List                                   HTML     33K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML     32K 
11: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     51K 
                Awarded Compensation                                             
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     37K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     34K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     34K 
17: R1          Cover Page                                          HTML     98K 
18: R2          Audit Information                                   HTML     38K 
19: R3          Consolidated Balance Sheets                         HTML    149K 
20: R4          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
21: R5          Consolidated Statements of Operations               HTML    159K 
22: R6          Consolidated Statements of Operations               HTML     46K 
                (Parenthetical)                                                  
23: R7          Condensed Consolidated Statements of Comprehensive  HTML     57K 
                Income (Loss)                                                    
24: R8          Consolidated Statements of Shareholders' Equity     HTML    130K 
25: R9          Consolidated Statements of Cash Flows               HTML    165K 
26: R10         Consolidated Statements of Cash Flows               HTML     44K 
                (Reconciliation of Cash)                                         
27: R11         Consolidated Statement of Cash Flows                HTML     34K 
                (Parenthetical)                                                  
28: R12         Organization and Basis of Presentation              HTML     43K 
29: R13         Summary of Significant Accounting Policies          HTML    107K 
30: R14         Discontinued Operations                             HTML     88K 
31: R15         Investments in Joint Ventures                       HTML     41K 
32: R16         Collaboration and Licensing Revenue                 HTML     66K 
33: R17         Short-term and Long-term Investments                HTML     58K 
34: R18         Fair Value Measurements                             HTML     61K 
35: R19         Property, Plant and Equipment, Net                  HTML     49K 
36: R20         Goodwill and Intangible Assets, Net                 HTML     59K 
37: R21         Lines of Credit and Long-Term Debt                  HTML     50K 
38: R22         Income Taxes                                        HTML    121K 
39: R23         Shareholders' Equity                                HTML     50K 
40: R24         Share-Based Payments                                HTML     90K 
41: R25         Commitments and Contingencies                       HTML     41K 
42: R26         Operating Leases                                    HTML     63K 
43: R27         Segments                                            HTML    109K 
44: R28         Defined Contribution Plans                          HTML     35K 
45: R29         Summary of Significant Accounting Policies          HTML    148K 
                (Policies)                                                       
46: R30         Summary of Significant Accounting Policies          HTML     70K 
                (Tables)                                                         
47: R31         Discontinued Operations (Tables)                    HTML     85K 
48: R32         Collaboration and Licensing Revenue (Tables)        HTML     58K 
49: R33         Short-term and Long-term Investments (Tables)       HTML     59K 
50: R34         Fair Value Measurements (Tables)                    HTML     58K 
51: R35         Property, Plant and Equipment, Net (Tables)         HTML     48K 
52: R36         Goodwill and Intangible Assets, Net (Tables)        HTML     65K 
53: R37         Lines of Credit and Long-Term Debt (Tables)         HTML     42K 
54: R38         Income Taxes (Tables)                               HTML    125K 
55: R39         Shareholders' Equity (Tables)                       HTML     40K 
56: R40         Share-Based Payments (Tables)                       HTML     89K 
57: R41         Operating Leases (Tables)                           HTML     64K 
58: R42         Segments (Tables)                                   HTML    105K 
59: R43         Organization and Basis of Presentation -            HTML     63K 
                Additional Information (Details)                                 
60: R44         Summary of Significant Accounting Policies -        HTML     75K 
                Additional Information (Details)                                 
61: R45         Summary of Significant Accounting Policies -        HTML     43K 
                Rollforward of Allowance for Credit Losses                       
                (Details)                                                        
62: R46         Summary of Significant Accounting Policies -        HTML     56K 
                Estimated Useful Lives of Property, Plant and                    
                Equipment (Details)                                              
63: R47         Summary of Significant Accounting Policies -        HTML     60K 
                Summary of Assumptions Used in Option Pricing                    
                Model (Details)                                                  
64: R48         Summary of Significant Accounting Policies -        HTML     43K 
                Potentially Dilutive Securities Excluded from                    
                Calculation of Net Loss per Share (Details)                      
65: R49         Discontinued Operations - Narrative (Details)       HTML     65K 
66: R50         Discontinued Operations - Summary of Financial      HTML     75K 
                Results for Trans Ova (Details)                                  
67: R51         Discontinued Operations - Summary of Significant    HTML     59K 
                Non-Cash Items, Investments and Purchases of                     
                Property, Plant and Equipment on Cash Flows -                    
                Trans Ova (Details)                                              
68: R52         Discontinued Operations - Summary of Financial      HTML     48K 
                Results for MBP Titan (Details)                                  
69: R53         Discontinued Operations - Summary Of Significant    HTML     43K 
                Non-Cash Items, Investments and Purchases of                     
                Property, Plant and Equipment on Cash Flows - MBP                
                Titan (Details)                                                  
70: R54         Investments in Joint Ventures - Intrexon Energy     HTML     52K 
                Partners - Additional Information (Details)                      
71: R55         Investments in Joint Ventures - Intrexon Energy     HTML     52K 
                Partners II - Additional Information (Details)                   
72: R56         Investments in Joint Ventures - Interests in        HTML     42K 
                Intrexon Energy Partners and Intrexon Energy                     
                Partners II (Details)                                            
73: R57         Collaboration and Licensing Revenue - Summarized    HTML     51K 
                Collaboration and Licensing Revenues (Details)                   
74: R58         Collaboration and Licensing Revenue - Additional    HTML     48K 
                Information (Details)                                            
75: R59         Collaboration and Licensing Revenue - Summary of    HTML     46K 
                Deferred Revenue (Details)                                       
76: R60         Short-term and Long-term Investments - Summary of   HTML     55K 
                Amortized Cost, Gross Unrealized Gains and Losses                
                and Fair Value of Investments (Details)                          
77: R61         Short-term and Long-term Investments - Narrative    HTML     35K 
                (Details)                                                        
78: R62         Fair Value Measurements - Summary of Placement in   HTML     60K 
                the Fair Value Hierarchy of Financial Assets that                
                are Measured at Fair Value on a Recurring Basis                  
                (Details)                                                        
79: R63         Fair Value Measurements - Additional Information    HTML     39K 
                (Details)                                                        
80: R64         Property, Plant and Equipment, Net - Schedule of    HTML     57K 
                Property, Plant and Equipment (Details)                          
81: R65         Property, Plant and Equipment, Net - Additional     HTML     40K 
                Information (Details)                                            
82: R66         Goodwill and Intangible Assets, Net - Schedule of   HTML     45K 
                Changes in Carrying Amount of Goodwill (Details)                 
83: R67         Goodwill and Intangible Assets, Net - Additional    HTML     52K 
                Information (Details)                                            
84: R68         Goodwill and Intangible Assets, Net - Schedule of   HTML     47K 
                Intangible Assets (Details)                                      
85: R69         Goodwill and Intangible Assets, Net - Schedule of   HTML     48K 
                Definite-Lived Intangible Assets, Estimated Future               
                Amortization Expense (Details)                                   
86: R70         Lines of Credit and Long-Term Debt - Lines of       HTML     44K 
                Credit - Additional Information (Details)                        
87: R71         Lines of Credit and Long-Term Debt - Short-Term     HTML     67K 
                Debt and Convertible Debt - Additional Information               
                (Details)                                                        
88: R72         Lines of Credit and Long-Term Debt - Components of  HTML     48K 
                Interest Expense (Details)                                       
89: R73         Income Taxes - Components of Loss Before Income     HTML     42K 
                Taxes (Details)                                                  
90: R74         Income Taxes - Components of Income Tax Benefit     HTML     53K 
                (Details)                                                        
91: R75         Income Taxes - Schedule of Effective Income Tax     HTML     61K 
                Rate Reconciliation (Details)                                    
92: R76         Income Taxes - Schedule of Deferred Tax Assets and  HTML     75K 
                Liabilities (Details)                                            
93: R77         Income Taxes - Summary of Valuation Allowance       HTML     47K 
                (Details)                                                        
94: R78         Income Taxes - Additional Information (Details)     HTML     48K 
95: R79         Shareholders' Equity - Additional Information       HTML     54K 
                (Details)                                                        
96: R80         Shareholders' Equity - Components of Accumulated    HTML     54K 
                Other Comprehensive Income (Loss) (Details)                      
97: R81         Share-Based Payments - Schedule of Stock-based      HTML     45K 
                Compensation Expense (Details)                                   
98: R82         Share-Based Payments - Additional Information       HTML     89K 
                (Details)                                                        
99: R83         Share-Based Payments - Schedule of Stock Option     HTML     74K 
                Activity (Details)                                               
100: R84         Share-Based Payments - Schedule of Restricted       HTML     63K  
                Stock Unit Activity (Details)                                    
101: R85         Commitments and Contingencies - Contingencies -     HTML     42K  
                Additional Information (Details)                                 
102: R86         Operating Leases - Additional Information           HTML     40K  
                (Details)                                                        
103: R87         Operating Leases - Components of Lease Costs        HTML     41K  
                (Details)                                                        
104: R88         Operating Leases - Maturities of Lease Liabilities  HTML     56K  
                (Details)                                                        
105: R89         Operating Leases - Lease Terms and Discount Rates   HTML     37K  
                (Details)                                                        
106: R90         Operating Leases - Other Information (Details)      HTML     37K  
107: R91         Segments - Adjusted EBITDA by Reportable Segment    HTML     40K  
                (Details)                                                        
108: R92         Segments - Reconciliation of Net Loss Before        HTML     85K  
                Income Taxes (Details)                                           
109: R93         Segments - Revenues by Reportable Segment           HTML     43K  
                (Details)                                                        
110: R94         Segments - Additional Information (Details)         HTML     50K  
111: R95         Segments - Goodwill (Details)                       HTML     51K  
112: R96         Defined Contribution Plans - Additional             HTML     34K  
                Information (Details)                                            
114: XML         IDEA XML File -- Filing Summary                      XML    216K  
117: XML         XBRL Instance -- pgen-20231231_htm                   XML   2.17M  
113: EXCEL       IDEA Workbook of Financial Report Info              XLSX    152K  
13: EX-101.CAL  XBRL Calculations -- pgen-20231231_cal               XML    286K 
14: EX-101.DEF  XBRL Definitions -- pgen-20231231_def                XML   1.00M 
15: EX-101.LAB  XBRL Labels -- pgen-20231231_lab                     XML   1.93M 
16: EX-101.PRE  XBRL Presentations -- pgen-20231231_pre              XML   1.46M 
12: EX-101.SCH  XBRL Schema -- pgen-20231231                         XSD    221K 
115: JSON        XBRL Instance as JSON Data -- MetaLinks              648±   924K  
116: ZIP         XBRL Zipped Folder -- 0001356090-24-000007-xbrl      Zip   2.26M  

‘ZIP’   —   XBRL Zipped Folder — 0001356090-24-000007-xbrl

This is an XBRL Zipped Folder.

	Download this zipped .zip folder
Files:	pgen-20231231.htm pgen-20231231.xsd pgen-20231231_cal.xml pgen-20231231_def.xml pgen-20231231_g1.jpg pgen-20231231_g10.jpg pgen-20231231_g11.jpg pgen-20231231_g12.jpg pgen-20231231_g13.jpg pgen-20231231_g14.jpg pgen-20231231_g15.jpg pgen-20231231_g16.jpg pgen-20231231_g17.jpg pgen-20231231_g18.jpg pgen-20231231_g19.jpg pgen-20231231_g2.jpg pgen-20231231_g20.jpg pgen-20231231_g21.jpg pgen-20231231_g22.jpg pgen-20231231_g23.jpg pgen-20231231_g24.jpg pgen-20231231_g25.jpg pgen-20231231_g26.jpg pgen-20231231_g27.jpg pgen-20231231_g28.jpg pgen-20231231_g3.jpg pgen-20231231_g4.jpg pgen-20231231_g5.jpg pgen-20231231_g6.jpg pgen-20231231_g7.jpg pgen-20231231_g8.jpg pgen-20231231_g9.jpg pgen-20231231_lab.xml pgen-20231231_pre.xml pgen-20231231xexx1010.htm pgen-20231231xexx1011.htm pgen-20231231xexx109.htm pgen-20231231xexx211.htm pgen-20231231xexx231.htm pgen-20231231xexx311.htm pgen-20231231xexx312.htm pgen-20231231xexx321.htm pgen-20231231xexx322.htm pgen-20231231xexx97.htm

21 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/23  Precigen, Inc.                    10-Q        6/30/23   93:17M
 7/06/23  Precigen, Inc.                    S-8         7/06/23    5:212K                                   Davis Polk & … LLP 01/FA
11/09/20  Precigen, Inc.                    10-Q        9/30/20  117:12M
 6/22/20  Precigen, Inc.                    S-3                    7:747K                                   Donnelley … Solutions/FA
 6/19/20  Precigen, Inc.                    8-K:5,9     6/19/20   11:175K                                   Donnelley … Solutions/FA
 6/04/20  Precigen, Inc.                    8-K:5,9     6/03/20   11:295K                                   Donnelley … Solutions/FA
 5/11/20  Precigen, Inc.                    10-Q        3/31/20  111:10M
 3/02/20  Precigen, Inc.                    10-K       12/31/19  141:33M                                    Workiva Inc Wde… FA01/FA
 2/04/20  Precigen, Inc.                    8-K:2,5,8,9 1/30/20   13:379K                                   Donnelley … Solutions/FA
 1/07/20  Precigen, Inc.                    8-K:5,9     1/01/20   11:240K                                   Donnelley … Solutions/FA
 8/09/19  Precigen, Inc.                    10-Q        6/30/19  116:12M
 6/12/19  Precigen, Inc.                    8-K:5,9     6/12/19    2:43K                                    Donnelley … Solutions/FA
 5/09/19  Precigen, Inc.                    10-Q        3/31/19  109:8.9M
 6/08/18  Precigen, Inc.                    8-K:5,9     6/07/18    2:36K                                    Donnelley … Solutions/FA
 3/01/18  Precigen, Inc.                    10-K       12/31/17  138:16M
 6/30/17  Precigen, Inc.                    8-K:5,9     6/28/17    2:35K                                    Donnelley … Solutions/FA
 6/13/16  Precigen, Inc.                    8-K:5,9     6/09/16    2:29K                                    Donnelley … Solutions/FA
 6/17/15  Precigen, Inc.                    8-K:5,9     6/11/15    3:101K                                   Donnelley … Solutions/FA
 1/14/15  Precigen, Inc.                    8-K:1,3,9   1/09/15    6:489K                                   Donnelley … Solutions/FA
 6/13/14  Precigen, Inc.                    8-K:5,9     6/09/14    5:407K                                   Donnelley … Solutions/FA
 7/29/13  Precigen, Inc.                    S-1/A                 15:5.3M                                   Donnelley … Solutions/FA